FTC Takes on PepsiCo’s Price Discrimination Tactics to Protect Smaller Retailers Under Robinson-Patman Act
January 17, 2025 — Following news that the Federal Trade Commission (FTC) has filed a lawsuit against PepsiCo for violating the Robinson-Patman Act (RPA) by granting discriminatory pricing and promotional advantages to a “large, big-box retailer” the American Economic Liberties Project released the following statement.
DOT Enforcement Action Ensures Airlines Don’t Promise Flights They Can’t Operate
January 16, 2025 — Following news that the U.S. Department of Transportation is filing a lawsuit against Southwest Airlines and for failing to address chronic problems on two routes—Chicago-Oakland and Baltimore-Cleveland—that caused 180 flight disruptions for five straight months, the American Economic Liberties Project released the following statement.
Economic Liberties Applauds FTC’s Landmark Lawsuit Against John Deere for Protecting Farmers’ Right to Repair
January 15, 2025 — Following the Federal Trade Commission’s lawsuit—joined by Illinois and Minnesota Attorneys General—against John Deere for its monopolistic repair restrictions that burden farmers with higher costs and devastating delays, the American Economic Liberties Project released the following statement.
DOJ Makes Clear That KKR Is Not Above the Law in Suit Against Private Equity Giant for HSR Violations and Antitrust Evasion
January 14, 2025 — Following news that the Department of Justice Antitrust Division has filed a lawsuit against private equity firm KKR for its serial violations of the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act), attempting to evade antitrust scrutiny for at least 16 separate transactions, the American Economic Liberties Project released the following statement.
PBMs Mark Up Life-Saving Drugs by as Much as 7,736%, New FTC Report Reveals
January 14, 2025 — Following the Federal Trade Commission’s unanimous 5-0 vote to release the second part of its 6(b) investigation into consolidated pharmacy benefit managers — the drug middlemen that rake in profit at the expense of patients and independent pharmacists — the American Economic Liberties Project released the following statement.